How to improve patient recruitment in your precision medicine research
Precision medicine research relies on genetic testing at scale, but has long suffered recruitment and…
Opinion-based articles written by experts working across different areas of the European biotechnology industry.
Precision medicine research relies on genetic testing at scale, but has long suffered recruitment and…
Chronic metabolic disorders like type 2 diabetes and cardiovascular disease are a huge burden on…
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
Biotechnology has the power to tackle global threats such as pandemics and climate change, but…
The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this…
As medical institutions develop the infrastructure for decentralized manufacturing of cell therapies, they are positioned…
How can we make clinical trial recruitment more reflective of the real world? Technology is…
Life sciences research often involves costly and complex procedures that take time away from experiment…
In recent years, artificial intelligence has been hailed as the next big thing in drug…
The next industrial revolution is going to be a bio-revolution. It has to be, given…
Biotech startups rely heavily on the science behind their products. There are a series of…
Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing…